Vikas Goyal is Director at Pandion Therapeutics, Inc. (PAND). They have made 4 open-market trades across 3 companies since 2017, most recently 2021-04-01.
CIK 0001721017
4 open-market purchases totalling $11.1M since 2017, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.